jane c. burns md - ucsd jacobs school of...

1

CURRICULUM VITAE

Jane C. Burns M.D.

EDUCATION

1974 B.A. Biology, Wesleyan University, Middletown, Connecticut

1978 M.D. with honors, University of North Carolina at Chapel Hill

POSTDOCTORAL TRAINING

1978-1981 Pediatric Internship and Residency, University of Colorado Health

Sciences Center School of Medicine, Denver, ColoradoLing

1981-1982 Pediatric Chief Resident, University of Colorado School of Medicine, Denver, Colorado

1982-1983 Pediatric Infectious Disease Fellow, University of Colorado School of

Medicine, Denver, Colorado 1983-1986 Research Fellow, Pediatric Infectious Diseases, Children's Hospital, Boston,

Massachusetts 1989-1991 Visiting Scholar in Molecular Genetics with Dr. Theodore Friedmann, Center

for Molecular Genetics, UCSD, La Jolla, California LICENSURE AND CERTIFICATION

l979 National Board of Medical Examiners #201652 1981 Colorado licensure 1983 Massachusetts licensure #56659 1983 American Board of Pediatrics, #028727 l990 California licensure, #G-68119

ACADEMIC APPOINTMENTS

1986 Instructor in Pediatrics, Harvard Medical School, Boston, Massachusetts

1989 Assistant Professor, Harvard Medical School, Boston, Massachusetts

l990 Assistant Professor, University of California School of Medicine, San Diego, CA

2

1995 Associate Professor, University of California School of Medicine, San Diego, CA 1999- Professor, University of California School of Medicine, San Diego, CA

2000-2012 Chief, Division of Allergy, Immunology, and Rheumatology, Dept. of Pediatrics,

University of California School of Medicine, San Diego HOSPITAL APPOINTMENTS

1986-1989 Assistant in Medicine (Infectious Disease), Children's Hospital, Boston, Massachusetts

1986-1989 Clinical Associate in Infectious Diseases, Dana Farber Cancer Institute, Boston,

Massachusetts 1989-1990 Associate in Medicine (Infectious Disease), Children's Hospital, Boston,

Massachusetts 4/1991-2010 Attending Staff, University of California, San Diego Medical Center, San Diego,

California 4/1991- Senior Attending Staff, Rady Children's Hospital, San Diego, California

OTHER PROFESSIONAL POSITIONS AND MAJOR VISITING APPOINTMENTS

1981-1983 Co-Director; Kawasaki Interdisciplinary Study Group, University of Colorado Health Sciences Center and The Children's Hospital, Denver, Colorado

1983-l989 Center Principal Investigator; Kawasaki Syndrome, IV Gamma globulin Trial,

The Children's Hospital, Boston, Massachusetts 1991- Director, Kawasaki Disease Research Program, University of California, San

Diego and Rady Children's Hospital, San Diego INTERNATIONAL EXPERIENCE 1977 Externship in pediatric medicine, Kaloleni, Kenya 1980 Externship in pediatric medicine, Kandy, Sri Lanka LANGUAGE SKILLS Fluent in French Conversant in Spanish and Italian

Jane C. Burns, M.D.

3

AWARDS AND HONORS

1984-1986 Charles A. Janeway Fellowship, Children's Hospital, Boston, Massachusetts 1985-1986 Wolbach Research Fellow Award, Children's Hospital, Boston, Massachusetts 1987 ICAAC Young Investigator Award, American Society for Microbiology 1992-1994 Shannon Award, NIH #R55 HL48825 1998 Elected Fellow, Infectious Disease Society of America 2001 UCSD School of Medicine Distinguished Faculty Lecturer 2006 Bidwai Memorial Lectureship, Chandigargh, India 2008 Yuki Takahashi Memorial Lectureship, 9th International KD Symposium, Taipei,

Taiwan 2009 Pioneer Award from KD Foundation for contribution to research on

Kawasaki Disease 2012 Hideko Ogawa Memorial lectureship, 10th International KD Symposium, Kyoto,

Japan 2014 Berry Memorial Lectureship, Postgraduate University, Chandigarh, Punjab, India

PATENTS

1996 "Generation, concentration, and efficient transfer of VSV-G pseudotyped retroviral vectors" US Patent # 5,512,421

1997 "Use of VSV-G pseudotyped vectors for transfer of genes into embryos" US Patent # 5,670,354

1999 "Pantropic retroviral vectors for gene transfer in mollusks" US Patent # 5,969,211 2000 "Method for creating transgenic animals", US Patent #6,080,912 2003 "Methods for creating transgenic animals", US Patent #6,548,740

Jane C. Burns, M.D.

4

2013 “Methods for diagnosis of Kawasaki disease” PCT/US2012/023739

COMMITTEE ASSIGNMENTS AND CONSULTANCIES

1986-l989 Committee on Clinical Investigation, Children's Hospital, Boston MA 1986-1989 Residency Training Committee for Clinical Research, Children's Hospital, Boston 1989-2006 Research Consultant, Roche Molecular Systems, Alameda, CA 1994-1997 UCSD School of Medicine, Admissions Committee 1994-2015 Board of Directors, Pangenix, San Diego, CA 1995-1997 UCSD School of Medicine, Executive Committee for Admissions 1997-1998 Standing and Promotions Committee, UCSD School of Medicine 1997-2001 Hillcrest Scientist Steering Committee, UCSD 2000-2009 Standing and Promotions Committee, Dept. of Pediatrics 2000-2005 Chair, Internal Grant Review Committee, SOM 2001-2005 Chair, Hillcrest Scientist Steering Committee, UCSD 2003-2015 American Heart Association Committee on Rheumatic fever,

Endocarditis, and Kawasaki disease 2002-2006 UCSD IRB Committee B 2002-2005 Chair, Organizing Committee, 8th International Kawasaki Disease

Symposium, San Diego, Feb.17-20, 2005 2006- Chair, IRB Committee D for pediatric protocols, UCSD

MEMBERSHIPS, OFFICES IN PROFESSIONAL SOCIETIES 1978-1983 Colorado Medical Society 1978-1983 Denver Medical Society 1988-2000 Member, American Society for Virology 1988- Fellow, Pediatric Infectious Disease Society 1991-2000 Member, American Society for Microbiology 1991- Member, Society for Pediatric Research 1994-2000 Member, Western Society of Pediatric Research 1994-1998 Faculty, Center for Marine Biology and Biomedicine, Scripps Institute of Oceanography, UCSD, La Jolla, CA 1998- Fellow, Infectious Disease Society of America 2003- Member, American Heart Association CURRENT RESEARCH INTERESTS

1. Kawasaki Disease: Clinical characterization, diagnosis, genetics, treatment, pathogenesis, and etiology PAST RESEARCH INTERESTS

1. Genetic engineering of disease resistance in non-mammalian species using pseudotyped retroviral vectors

Jane C. Burns, M.D.

5

2. Antimicrobial peptides and innate immunity 3. Diagnostic virology

UNDERGRADUATE STUDENTS TRAINED: 1992 Alka Malhotra, UCSD Class of 1993 1993 Grace Lozinski, UCSD Class of 1993 1994 Jennifer Brown, UCSD Class of 1995 1995 Melissa Schoenwetter, UCSD Class of 1996 1996 Kimberly Best, UCSD Class of 1997 1996 Laura Dengler, U Penn. Class of 1995 1996 David Bronstein, UCSD Class of 1997 1998 Amy Dille, UCSB, Class of 1999 2000 Erin Miller, UCSB, Class of 2004 2001-2003 Christina Lin, Wellesley College, Class of 2005 2003-2004 Mathew Leach, Bowdoin College, Class of 2005 2004-2005 Susan Wang, Bronx High School of Science, Senior 2004-2005 Vivy Dang, UCSD, Class of 2007 2005-2007 Julia Eichenfield, Bishop’s School, Junior 2005-2006 Rachel Abbott, UCSD Class of 2007 2005-2007 An Au, UCSD Class of 2007 2006-2009 Beth Griffiths, UCSD, Class of 2009 2009-2010 Pierre Amog, Class of 2011 2010-2011 Ramina Amino, Class of 2011 2010-2012 Kayla Ueda, Class of 2012 2010-2012 Kareem Moasis, Class of 2012 2011-2012 Jonathan Lin, Class of 2012 2013-2014 Mandeep Bajwa, Class of 2014 THESIS COMMITTEE MEMBER 1997-1999 Viviane Boulo, Doctoral candidate, Univ. of Montpellier, France 2003-2005 Marissa Braff, Molecular Pathology Graduate Program, UCSD 2002-2005 Annie Kao, SDSU/UCSD Combined Doctorate Program in

Epidemiology 2009-2011 Yuichiro Sato, BS/MS program, Biology (JCB Chair) 2010-2011 Jen Lundergren, BS/MS program, Biology (JCB Chair) 2012-2013 Christine Trinh, BS/MS program, Biology (JCB Chair) 2011-2012 Sherif Risk, Masters in Advanced Studies in Medicine, University

of Cairo, Dept. of Medicine, Cairo, Egypt 2013-2014 Aaron Lee, BS/MS program, Biology (JCB Chair) 2014- Cassidy Huang, BS/MS program, Biology (JCB Chair)

Jane C. Burns, M.D.

6

UCSD MEDICAL STUDENT ISP COMMITTEE MEMBER OR CHAIRPERSON FOR: 1994 Robert Enguidanos, Class of 1995 (Chair) 1994 Joan C. Wu, Class of 1995 1995 Duy D. Nguyen, Class of 1996 1996 Emily Ting, Class of 1999 (Chair) 1997 Ted Omachi, Class of 2000 (Chair) 1997 Doojin Kim, Class of 2000 1997 David Bronstein, Class of 2001 (Chair)

1999 1999 Frances Faro, Class of 2002 (Chair) 2000 Jennie Buchanan, Class of 2003 (Chair) 2000 Pia Pannaraj, Class of 2001 (Chair) 2001 Marina Dergun, Class of 2004 (Chair) 2001 Katrine Zhiroff, Class of 2004 (Chair) 2002 Matt Wilder, Class of 2005 (Chair) 2003 Ada Ho, Class of 2006 (Chair) 2003 Lily Jih, Class of 2006 (Chair) 2004 Nidhi Pandoh, Class of 2007 (Chair) 2005 Rahim Aimaq, Class of 2008 (Chair) 2006 Suchan Song, Class of 2009 (Chair) 2008 Alison Sheridan, Class of 2011 (Chair) 2008 Kevin Lin, Class of 2011 (Chair) 2009 Vera Trofimenko, Class of 2012 (Chair) 2010 Mathew Tjiadi, Class of 2013 2011 Hubert Lau, Class of 2014 (Chair) 2012 Victoria Liu, Class of 2015 (Chair) 2013 Ellen Haddock, Class of 2016 2014 Saloni Shah, Class of 2017 2014 Vidya Mahavadi, Class of 2017 (Chair) POSTDOCTORAL FELLOWS TRAINED: 1992-1995 Dr. Hiroko Shimizu, Univ. of Yokohama, Japan 1994-1996 Dr. Chisato Shimizu, Univ. of Yokohama, Japan 1994-1996 Dr. Tomoyo Matsubara, Juntendo University, Tokyo, Japan 1996-1997 Dr. Qun Fang, Guanjo University, China 1999-2000 Dr. Viviane Boulo, Univ. of Montpellier, France 2000-2001 Dr. Xavier Lauth, Univ. of Strasbroug, France 2006 Dr. Elena Corinaldesi, Univ. of Bologna, Italy 2007-2009 Dr. Adriana Tremoulet, UCSD Infectious Disease Fellow 2007-2008 Dr. Ginger Watson, Baylor Dept. of Surgery 2008-2013 Dr. Susan Fernandez, Manilla, Philippines

Jane C. Burns, M.D.

7

2012-2014 Dr. Shohei Ogata, Kitasato Medical University, Japan 2013-2015 Dr. Fujito Numano, Nigata Medical College, Japan 2015- Dr. Jun Oyamada, Akita Medical University, Japan RESEARCH ELECTIVE FOR PEDIATRIC RESIDENTS: 2005-2007 Dr. Matt Wilder 2007-2008 Dr. Helen Harvey 2009-2011 Dr. Hannah Wolford 2013-2014 Dr. Jefferson Jones 2014-2015 Dr. Stephanie Schroeder COURSES TAKEN: 1986 Clinical Trials, Harvard School of Public Health, Boston, Massachusetts 1993 Conversational Japanese, UCSD Extension 1995 Biology of Disease Vectors, Colorado State University, Fort Collins CO

BIBLIOGRAPHY A. Original Reports 1. Burns JC, Berman E, Fagre JL, Shikes RH, and Lum GM: Pancreatic islet cell necrosis

complicating hemolytic uremic syndrome. J Pediatr. 100:541-545,1982. (PMID: 7038078)

2. Patriarca PA, Rogers MF, Morens DM, Schoenberger LB, Kaminski RM, Burns JC, Glode MP: Kawasaki Syndrome: Association with the application of rug shampoo. Lancet. 2:578-580,1982. (PMID: 6125730)

3. Kahler S, Burns JC, Aylsworth AS: The mild recessive form of osteopetrosis. Am J Human Genetics. 17:451-464,1984. (PMID: 6702897)

4. Burns JC, Glode MP, Clarke SH, Wiggins J, Hathaway WE: Coagulopathy and platelet activation in Kawasaki Syndrome: Identification of patients at high-risk for development of coronary artery aneurysms. J Pediatr. 105:206-211,1984. (PMID: 6235335)

5. McGregor J, Burns JC, Levin MJ, Burlington B, and Meiklejohn G: Transplacental passage of Influenza A/Bangkok (H3N2) mimicking amniotic fluid infection syndrome. Am J Obstet Gynecol. 149:856,1984. (PMID: 6465250)

6. McIntosh K, Kurachek SC, Cairns LM, Burns JC and Goodspeed B: Treatment of respiratory viral infection in an immunodeficient infant with ribavirin aerosol. Am J Dis Child. 138:305-308,1984. (PMID: 6322573)

7. Burns JC, Joffe L, Sargent R, Glode MP: Anterior uveitis in Kawasaki Syndrome. Ped Infect Dis. J. 4:258-261,1985. (PMID: 4039819)

8. Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, duffy CE, Glode MP, Mason WH, Reddy V, Sanders SP, Shulman ST, Wiggins JW, Hicks RV, Fulton DR, Lewis AB, Leung DYM, Colton T, Rosen FS, Melish M. Treatment of Kawasaki Syndrome with intravenous gamma globulin. N Engl J Med. 315:341-347,1986. (PMID:

Jane C. Burns, M.D.

8

2426590) 9. Burns JC, Geha RS, Schneeberger EE, Newburger JW, Rosen FS, Glezen LS, Huang AS,

Natale J and Leung DYM: Polymerase activity in lymphocyte culture supernatants from patients with Kawasaki disease. Nature. 323:814-816,1986. (PMID: 2447591)

10. Burns JC, Wiggins JW, Toews WH, Newburger JW, Leung DYM, Wilson H, Glode MP: The clinical spectrum of Kawasaki Syndrome in infants less than six months of age. J Pediatr. 109:759-763,1986. (PMID: 3772656)

11. Glode MP, Joffe LS, Brogden R, Leung DYM, Burns JC, Arlian L: Kawasaki Syndrome in the absence of house dust mite exposure. Pediatr Inf Dis J. 5:644-648,1986. (PMID: 3797297)

12. Leung DYM, Geha RS, Newburger JW, Burns JC, Fiers W, Lapierre LA, Prober JS: Two monokines, Interleukin 1 and Tumor Necrosis Factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki Syndrome. J Exp Med. 164:1958-1972,1986. (PMID: 3491174)

13. Leung DYM, Burns JC, Newburger JW, Rosen FS, Geha RS: Reversal of lymphocyte activation in vivo in the Kawasaki Syndrome by intravenous Gamma globulin. J Clin Invest. 79:468-472,1987. (PMID: 2433307)

14. Hendry RM, Burns JC, Walsh EE, Graham BS, Wright PF, Hemming VG, Rodriguez WJ, Kim HW. Prince GA, McIntosh K, Murphy BR: Strain-specific serum antibody response in infants undergoing primary infection with respiratory syncytial virus. J Inf Dis. 157:640-647,1988. (PMID: 3346563)

15. Brosius CL, Newburger JW, Burns JC, Hojonowski-Diaz P, Leung DYM: Association of Kawasaki Syndrome with atopic dermatitis. Ped Inf Dis J. 7:863-866,1988. (PMID: 3211629)

16. Newburger JW, Sanders SP, Burns JC, Parness IA, Beiser AS, Colan SD: Left ventricular contractility and function in Kawasaki syndrome: Effect of intravenous Gamma globulin. Circulation. 79:1237-1246,1989. (PMID: 2720925)

17. April MM, Burns JC, Newburger JW, Healy GB: Kawasaki disease and cervical adenopathy: An update for the otolaryngologist. Arch. Otolaryngology. 115:512-514,1989. (PMID: 2923695)

18. Salzman AL, Hoffer FA, Burns, JC: Chronic hip pain and limp in a three-year old girl. Rev Inf Dis. 11:341-348,1989. (PMID: 2704930)

19. Leung DYM, Cotran RS, Kurt-Jones E, Burns JC, Newburger JW, Pober JS: Endothelial cell activation and increased IL-1 secretion in acute Kawasaki disease. Lancet. I, 1298-1302,1989. (PMID: 2480498)

20. Burns JC, Huang AS, Newburger JW, Reinhart AL, Walsh MM, Leung DYM: Characterization of the polymerase activity associated with cultured peripheral blood mononuclear cells from patients with Kawasaki disease. Pediatric Research. 27:109-112,1990. (PMID: 1690383)

21. Rubio N, Hoch S, Naya F, Burns JC: Absence of reverse transcriptase activity associated with cultured peripheral blood mononuclear cells from patients with systemic onset juvenile rheumatoid arthritis. Letter to Editor, Arthritis and Rheumatism. 34:126,1991.

Jane C. Burns, M.D.

9

(PMID: 1701996) 22. Newburger JW, Burns JC, Beiser AS, Loscalzo J: Altered lipid metabolism following

Kawasaki syndrome. Circulation. 84:625-631,1991. (PMID: 1860206) 23. Sundel RP, Newburger JW, McGill T, Cleveland SS, Miller W, Berry B, Burns JC:

Sensorineural hearing loss associated with Kawasaki disease. J Pediatr. 117:71-77,1990. (PMID: 2391591)

24. Burns JC, Mason WH, Glode MP, Shulman ST, Melish ME, Meisner C, Bastian J, Beiser AS, Meyerson HM, Newburger JW and the U.S. Multicenter Kawasaki Study Group. Clinical and epidemiological characteristics of patients referred for evaluation of possible KD. J Pediatr. 118:680-686,1991. (PMID: 2019921)

25. Burns JC, Felsburg PJ, Wilson H, Scott-Moncrieff C, Snyder PW, Rosen FS, Glickman LT: Canine Pain Syndrome: A model for the study of Kawasaki Disease. Perspectives in Biology and Medicine 35:68-73,1991. (PMID: 1780217)

26. Koren, G, Sundel R, Edney P, Newburger JW, Klein J, Laxer R, Giesbrecht E, Silverman E, Burns JC: Decreased protein binding of salicylates in Kawasaki Disease. J Pediatr. 118:456-9,1991. (PMID: 1999792)

27. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy E, Fulton DR, Glode MP, Mason WH, Meissner C, Rowley AH, Shulman ST, Reddy V, Sundel RP, Wiggins JW, Colton T, Melish ME, Rosen FS: Single infusion of intravenous gamma globulin compared to four daily doses in the treatment of acute Kawasaki Syndrome. New Engl J Med. 1991;324:1633-9,1991. (PMID: 1709446)

28. Finberg RW, Newburger JW, Mikati MA, Heller A, Burns JC: High dose intravenous globulin treatment enhances natural killer cell activity in Kawasaki Disease. J Pediatr. 120:376-380,1992. (PMID: 1538283)

29. Siber GR, Leszczynski J, Pena-Cruz V, Ferren-Gardner C, Anderson R, Hemming VG, Burns JC, McIntosh K, Gonin R, Anderson LJ: Preparation of a human respiratory syncytial virus immune globulin. J Inf Dis. 165:456-463, 1992. (PMID: 1538152)

30. Sundel RP, Cleveland SS, McGill T, Beiser AS, Novak RE, Newburger JW, Koren G, Harris JB, Burns JC: Audiologic profiles of children with acute KD. American Journal of Otology. 13:512-515, 1992. (PMID: 1280407)

31. Fildes N, Burns JC, Newburger J, Klitz W, Begovich AB: The HLA Class II region and susceptibility to Kawasaki disease. Tissue Antigens 39:99-101,1992. (PMID: 1574805)

32. Burns JC, Friedmann T, Driever W, Burrascano M, Yee J-K: Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. 90:8033-8037, 1993. (PMID: 8396259)

33. Sundel RP, Burns JC, Baker A, Beiser AS, Newburger JW: Gamma globulin re-treatment in Kawasaki disease. J Pediatr. 123:657-659, 1993. (PMID: 8410524)

34. Shimizu H, McCarthy CA, Smaron MF, Burns JC: Polymerase chain reaction for detection of measles virus in clinical samples. J Clin Micro. 31:1034-1039, 1993. (PMID: 8501204)

35. Burns JC, Newburger JW, Sundel R, Wyatt LS, Frenkel N: Seroprevalence of human

Jane C. Burns, M.D.

10

herpesvirus 7 in patients with Kawasaki Disease. Letter to the Editor, Ped Inf Dis J. 13:168-169, 1994. (PMID: 8190553)

36. Shimizu H, Shimizu C, Burns JC: Detection of novel RNA viruses: Morbilliviruses as a model system. Mol. and Cellular Probes, 8:209-214,1994. (PMID: 7969194)

37. Lozinski GM, Davis GG, Krous HF, Billman GF, Shimizu H, Burns JC: Adenovirus myocarditis: retrospective diagnosis by gene amplification from formalin-fixed, paraffin-embedded tissues. Human Pathology, 25:831-834, 1994. (PMID: 8056426)

38. Burns JC, Matsubara T, Lozinski G, Yee J-K, Friedmann T, Washabaugh CH, Tsonis PA. Pantropic retroviral vector-mediated gene transfer, integration, and expression in newt limb cells. Develop. Biol., 165:285-289, 1994. (PMID: 8088445)

39. Yee J-K, Miyanohara A, LaPorte P, Bouic K, Burns JC, Friedmann T.: Generation of high titer, pantropic retroviral vectors: efficient gene transfer into hepatocytes. Proc. Natl. Acad. Sci 91:9564-9568, 1994. (PMID: 7937806)

40. Shimizu H, Schnurr DP, Burns JC. Comparison of methods to detect enteroviral genome in frozen and fixed myocardium by polymerase chain reaction. Laboratory Investigation 71:612-615, 1994. (PMID: 7967516)

41. Lin S, Gaiano N, Yee J-K, Culp P, Burns JC, Friedmann T, Hopkins N: Integration and germline transmission of a pseudotyped retroviral vector in zebrafish. Science, 265:666-669, 1994. (PMID: 8036514)

42. Burns JC, Wright JD, Newburger JW, Schneeberger EE, Mierau GW, Smith LE. Conjunctival biopsy in patients with Kawasaki Disease. Pediatric Pathology, 15:547-553, 1995. (PMID: 8597841)

43. Shimizu C, Rambaud C, Cheron G, Rouzioux C, Lozinski GM, Rao A, Stanway G, Krous HF, Long C, Burns JC. Molecular identification of viruses in sudden infant death associated with myocarditis. Ped. Inf. Dis. J. 14:584-588, 1995. (PMID: 7567286)

44. Burns JC, McNeil L, Shimizu C, Matsubara T, Yee J-K, Friedmann, T, Kurdi-Haidar B, Maliwat E, Holt CE: Retroviral gene transfer in Xenopus cell lines and embryos. In Vitro Cell. Dev. Biol. 32:78-84, 1996. (PMID: 8907120)

45. Tanel RE, Kao S-Y, Niemiec TM, Loeffelholz MJ, Holland DT, Shoaf LA, Stucky ER, Burns JC. Prospective comparison of culture vs genome detection for diagnosis of enteroviral meningitis in childhood. Arch. of Pediatrics and Adol Med.150:919-924, 1996. (PMID: 8790121)

46. Matsubara T, Beeman RW, Shike H, Besansky NJ, Mukabayire O, Higgs S, James AA, Burns JC. Pantropic retroviral vectors integrate and express in cells of the malaria mosquito, Anopheles gambiae. Proc. Natl. Acad. Sci.93:6181, 1996. (PMID: 8650240)

47. Lu J-K, Chen TT, Allen SK, Matsubara T, Burns JC. Production of transgenic dwarf surfclams, Mulinia lateralis, with pantropic retroviral vectors. Proc. Natl. Acad. Sci.93:3482-3486, 1996. (PMID: 8622962)

48. Matsubara T, Mason W, Kashani IA, Kligerman M, Burns JC. Gastrointestinal hemorrhage complicating aspirin therapy in acute Kawasaki Disease. J. Ped. 128:701-703, 1996. (PMID: 8627447)

49. Burns JC, Shike H, Gordon JB, Malhotra A, Schoenwetter M, Kawasaki T. Sequelae of

Jane C. Burns, M.D.

11

Kawasaki disease in adolescents and young adults. J Am Coll Cardiol.28:253-257, 1996. (PMID: 8752822)

50. Lu J-K, Burns JC, Chen TT. Pantropic retroviral vector integration, expression, and germline transmission in medaka (Oryzias latipes). Molec. Marine Biol. and Biotech. 6:289-95, 1997. (PMID: 9418287)

51. Bronstein DE, Besser RE, Burns JC. Passive surveillance for Kawasaki Disease in San Diego County. Ped Inf Dis J. 16:1015-8, 1997. (PMID: 9384331)

52. Chan AWS, Homan JE, Ballou LU, Burns JC, Bremel RD. Transgenic cattle produced by reverse-transcribed gene transfer in oocytes. Proc. Natl. Acad. Sci. 95:14028-14033, 1998. (PMID: 9826647)

53. Jordan TV, Shike H, Boulo V, Cedeno V, Fang Q, Davis BS, Jacobs-Lorena M, Higgs S, Fryxell KJ, Burns JC. Pantropic retroviral vectors mediate somatic cell transformation and expression of foreign genes in dipteran insects. Insect Molecular Biology. 7: 215-222, 1998. (PMID: 9662470)

54. Teysset L, Burns JC, Shike H, Sullivan BL, Bucheton A, Terzian C. A Moloney murine leukemia virus-based retroviral vector pseudotyped by the insect retroviral gypsy envelope can infect Drosophila cells. J.Virol. 72:853-856, 1998. (PMID: 9420299)

55. Ting EC, Capparelli EV, Billman GF, Lavine JE, Matsubara T, Burns JC. Elevated gamma-glutamyl transferase concentrations in patients with acute Kawasaki disease. Ped. Inf. Dis. J. 17:431-432, 1998. (PMID: 9613663)

56. Franco MD, Rogers ME, Shimizu C, Shike H, Vogt RG, Burns JC. Infection of lepidoptera with a pseudotyped retroviral vector. Insect Biochem. Mol. Biol. 28:819-825, 1998. (PMID: 9818383)

57. Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP and the Multicenter KD Study Group. Intravenous gamma globulin treatment and retreatment in Kawasaki Disease. Ped. Inf. Dis. J.17:1144-8, 1998. (PMID: 9877364)

58. Dengler LD, Capparelli EV, Bastian JF, Bradley DJ, Glode MP, Santa S, Newburger JW, Baker AL, Matsubara T, Burns JC. Cerebrospinal fluid profile in patients with acute Kawasaki Disease. Ped. Inf. Dis. J.17:478-481, 1998. (PMID: 9655538)

59. Beiser AS; Takahashi M; Baker AL; Sundel RP; Newburger JW and the US Multicenter Kawasaki Disease Study Group. A predictive instrument for coronary artery aneurysms in Kawasaki disease. American Journal of Cardiology, 81(9):1116-20, 1998. (PMID: 9605052)

60. Que X, Kim D, Alagon A, Hirata K, Shike H, Shimizu C, Gonzalez A, Burns JC, Reed SL. Pantropic retroviral vectors mediate stable gene transfer and expression in Entamoeba histolytica. Molecular and Biochemical Parasitology 99:237-245, 1999. (PMID: 10340487)

61. Moran AM, Newburger JW, Sanders SP, Parness IA, Spevak PJ, Burns JC, Colan SD. Abnormal myocardial mechanics in Kawasaki Syndrome: Rapid response to gamma globulin. Am. Heart J.139:217-23, 2000. (PMID: 10650293)

62. Boulo V, Cadoret JP, Shike H, Shimizu C, Miyanohara A, Burns JC. Infection of cultured embryo cells of the Pacific oyster, Crassostrea gigas, by pantropic retroviral vectors. In

Jane C. Burns, M.D.

12

Vitro Cell. Devel. Biol. 36:395-399, 2000. (PMID: 10949999) 63. Komoto N, Thibert C, Boulo V, Fang Q, Burns JC, Couble P. Transduction of silkworm

embryos with a pseudotyped retroviral vector. Japanese Sericultural Science Jpn, 69: 55-61, 2000.

64. Shike H, Shimizu C, Klimpel KS, Burns JC. Expression of foreign genes in primary cultured cells of the blue shrimp, Penaeus stylirostris. Marine Biology 137:605-611, 2000.

65. Burns JC, Kushner HI, Bastian JF, Shike H, Shimizu C, Matsubara T, Turner CL. Kawasaki disease: A brief history. Pediatrics [online] 106:URL: http://www.pediatrics.org/cgi/content/full/106/2/e27, 2000. (PMID: 10920183)

66. Eberhard BA, Sundel RP, Newburger JW, Baker A, Fuhlbrigge RC, Burns JC, Gellis SE. Psoriatic eruption in Kawasaki disease. J Pediatr 137:578-580, 2000. (PMID: 11035843)

67. Schrag SJ, Besser RE, Olson C, Burns JC, Arguin PM, Giminex-Sanchez F, Stevens VA, Pruckler JM, Fields BS, Belay ED, Ginsberg M, Dowell SF. Lack of association between Kawasaki syndrome and Chlamydia pneumoniae infection: an investigation of a Kawasaki syndrome cluster in San Diego County. Ped Inf Dis J 19:17-22, 2000. (PMID: 10643845)

68. Shike H, Dhar AK, Burns JC, Shimizu C, Jousset X, Klimpel KR, Bergoin M. Infectious hypodermal and hematopoietic necrosis virus of shrimp is related to mosquito brevidensoviruses. Virology 277:167-177, 2000. (PMID: 11062047)

69. Bronstein DE, Dille AN, Austin JP, Williams CM, Palinkas LA, Burns JC. Relationship of climate, ethnicity, and socioeconomic status to Kawasaki Disease in San Diego County, 1994-1998. Ped. Inf. Dis. J. 19:1087-1091, 2000. (PMID: 11099092)

70. Quasney MW, Bronstein DE, Cantor RM, Zhang Q, Stroupe C, Shike H, Bastian JF, Matsubara T, Fujiwara M, Akimoto K, Newburger JW, Burns JC. Increased frequency of alleles associated with elevated TNF-alpha levels in children with Kawasaki disease. Pediatr. Research 49:686-690, 2001. (PMID: 11328953)

71. Knott PD, Orloff LA, Harris JP, Novak RE, Burns JC for the Kawasaki Disease Multicenter Hearing Loss Study Group. Sensorineural hearing loss and Kawasaki disease: A prospective study. American Journal of Otolaryngology 22:343-348, 2001. (PMID: 11562886)

72. Shimizu C, Shike H, Klimpel KR, Burns JC. Hemolymph analysis and evaluation of newly formulated media for culture of shimp cells (Penaeus stylirostris). In Vitro Cellular Develop. Biol. Animal. 37:322-329, 2001. (PMID: 11515962)

73. Lauth X, Shike H, Westerman M, Ostland V, Carlberg J, Van Olst J, Nizet V, Taylor S, Shimizu C, Burns JC, Bulet P. Discovery and characterization of two isoforms of a novel antimicrobial peptide from hybrid striped bass. J. Biol. Chem 277:5030-5039, 2002. (PMID: 11739390)

74. Paul TA, Burns JC, Shike H, Getchell R, Bowser PR, Whitlock KE, Casey JW. Reporter gene expression in fish following cutaneous infection with pantropic retroviral vectors. Marine Biotechnol. 3: 81-87, 2001. (PMID: 14961303)

75. Shike H, Lauth X, Westerman M, Ostland VE, Carlberg JM, Van Olst JC, Shimizu C,

Jane C. Burns, M.D.

13

Bulet P, Burns JC. Bass hepcidin is a novel antimicrobial peptide induced by bacterial challenge. European Journal of Biochem 269:2232-2237, 2002. (PMID: 11985602)

76. Kushner HI, Bastian JF, Turner CL, Burns JC. Rethinking the boundaries of Kawasaki Disease. Perspectives in Biology and Medicine 2003;46:216-233. (PMID: 12721522)

77. Blanchard JN, Powell HC, Freeman WR, Letendre S, Balnchard D, Shimizu C, Burns JC. Recurrent Kawasaki disease-like syndrome in an AIDS patient. Clin Infect Dis J 2003;36:105-111. (PMID: 12491210)

78. Shimizu C, Shike H, Malicki D, Breisch E, Westerman M, Buchanan J, Ligman H, Phillips R, Carlberg J, van Olst J, Burns JC. Characterization of a white bass (Morone chrysops) embryonic cell line with epithelial features. In Vitro Cell Develop Biol. 2003;39:29-35. (PMID: 12892524)

79. Best BM, Burns JC, DeVincenzo J, Phelps SJ, Blumer JL, Wilson JT, Capparelli EV, Connor JC. Pharmacokinetic and tolerability assessment of a pediatric oral formulation of pentoxifylline in Kawasaki disease. Currr Ther Res Clin Exp. 2003;64:96-115.

80. Faro FD and Burns JC Lipid peroxidation and Kawasaki disease. Pediatr Cardiol. 2003;24:611-612. (PMID: 12784125)

81. Kushner HI, Turner CL, Bastian JF, Burns JC. The narratives of Kawasaki disease. Bulletin of the History of Medicine. 2004;78:410-439. (PMID: 15211054)

82. Shike H, Shimizu C Lauth X, Burns JC. Organization and expression analysis of the zebrafish hepcidin gene, an antimicrobial peptide gene conserved among vertebrates. Developmental and Comparative Immunology 2004;28:747-754. (PMID: 15043943)

83. Pannaraj PS, Turner CL, Bastian JF, Burns JC. Failure to diagnose Kawasaki disease at the extremes of the pediatric age range. Ped Inf Dis J. 2004;23:789-791. (PMID: 15295237)

84. Kushner HI, Burns JC, Bastian JF, Turner CL. The histories of Kawasaki disease. Prog Pediatr Cardiol. 2004;19:91-97.

85. Burns JC, Cayan DR, Tong F, Turner CL, Shike H, Kawasaki T, Nakamura Y, Yashiro M, Yanagawa H. Seasonality and temporal clustering of Kawasaki Syndrome in Japan, 1987-2000. Epidemiology 2005;16:220-225. (PMID: 15703537)

86. Shike H, Shimizu C, Kanegaye J, Foley JL, Burns JC. Quantitation of adenovirus genome during acute infection in normal children. Pediatr Inf Dis J 2005;24:29-33. (PMID: 15665707)

87. Dergun M, Kao A, Hauger SB, Newburger JW, Burns JC. Kawasaki syndrome pedigrees. Arch Pediatr Adol Med 2005;159:876-881. (PMID: 16143748)

88. Burns JC, Shimizu C, Gonzalez E, Kulkarni H, Patel S, Shike J, Sundel RS, Newburger JW, Ahuja SK. Genetic variations in the receptor-ligand pair, CCR5 and CCL3L1, are important determinants of susceptibility to Kawasaki disease. J Infect Dis. 2005;192:344-349. (PMID: 15962231)

89. Burns JC, Shimizu C, Shike H, Newburger JW, Sundel RS, Matsubara T, Yuichi Ishikawa, Cheng S, Grow MA, Steiner L, Brophy VA, Cantor R. Family-based association analysis of genes in inflammatory and cardiovascular pathways implicates IL-4 in Kawasaki Disease. Genes and Immunity 2005;6:438-444. (PMID: 15889128)

Jane C. Burns, M.D.

14

90. Burns JC, Mason WH, Hauger SB, Janai H, Bastian JF, Wohrley JD, Balfour I, Shen CA, Michel ED, Shulman ST, Melish ME. Infliximab treatment for refractory Kawasaki syndrome. J Pediatr. 2005;146:662-667. (PMID: 15870671)

91. Shike H, Shimizu C, Kanegaye J, Foley JL, Schnurr DP, Wold LJ, Burns JC. Adenovirus, adeno-associated virus, and Kawasaki disease. Pediatr Inf Dis J 2005;24:1011-1014. (PMID: 16282942)

92. Shimizu C, Shike H, Baker SC, Garcia F, van der Hoek L, Kuijpers TW, Reed SL, Rowley AH, Shulman ST, Talbot HKB, Williams JV, Burns JC. Human coronavirus NL63 is not detected in the respiratory tract of children with acute Kawasaki disease. J Infec Dis 2005;192:1767-1771. (PMID: 16235175)

93. Belay ED, Erdman DD, Anderson LJ, Peret TC, Schrag SJ, Fields BS, Burns JC, Schonberger LB. Kawasaki disease and human coronavirus. J Infect Dis 2005;192:352-353. (PMID: 15962234)

94. Baker SC, Shimizu C, Shike H, Garcia F, van der Hoek L, Kuijpers TW, Reed SL, Rowley AH, Shulman ST, Talbot HK, Williams JV, Burns JC. Human coronavirus-NL63 infection is not associated with acute Kawasaki disease. Adv Exp Med Biol. 2006;581:523-6. (PMID: 17037590)

95. Wilder MS, Palinkas LA, Kao AS, Bastian JF, Burns JC. Delayed diagnosis by physicians contributes to the development of coronary artery aneurysms in patients with Kawasaki syndrome. Ped Inf Dis J. 2007;26: 256-260. (PMID: 17484225)

96. Popper SJ, Shimizu C, Shike H, Kanegaye JT, Newburger JW, Sundel RS, Brown PO, Burns JC, Relman DA. Gene-expression patterns reveal underlying biological processes in Kawasaki disease. Genome Biology 2007;8:R261. (PMID: 18067656)

97. Kurio G, Zhiroff K, Jih L, Fronek A, Burns JC. Non-invasive determination of endothelial cell function in the microvasculature in Kawasaki syndrome. Pediatric Cardiology. 2008;29:121-125. (PMID: 17891433)

98. Kao AS, Getis A, Brodine S, Burns JC. Spatial and temporal clustering of Kawasaki syndrome cases. Ped Inf Dis J. 2008;27:981-985. (PMID: 18852687)

99. Tremoulet AH, Best BM, Song S, Wang S, Corinaldesi E, Eichenfield J, Burns JC. Resistance to intravenous immunoglobulin in children with Kawasaki Disease. J Pediatr. 2008;153:117-121. (PMID: 18571548)

100. Burns JC, Best BM, Mejias A, Mahony L, Fixler DE, Jafri HS, Melish ME, Jackson MA, Asmar B, Lang D, Connor JD, Capparelli EV, Keen ML, Mamun K, Keenan G, Ramilo O. Infliximab treatment of IVIG-resistant Kawasaki disease. J Pediatr 2008 153(6):833-8. (PMID: 18672254)

101. Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, Yashiro M, Nakamura Y, Yanagawa H, Wakui K, Fukushima Y, Kishi F, Hamamoto K, Terai M, Sato Y, Ouchi K, Saji T, Narai A, Kaburagi Y, Yoshikawa T, Suzuki K, Tanaka T, Nagai T, Cho H, Fujino A, Sekine A, Nakmuchi R, Tatsuhiko T, Kawasaki T, Nakamura Y, Hata A. IPTKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nature Genetics 2008 Jan;40(1):35-42. (PMID: 18084290)

102. Kushner HI, Bastian JF, Turner CL, Burns JC. The two emergences of Kawasaki

Jane C. Burns, M.D.

15

syndrome and the implications for the developing world. Pediatr Infect Dis J. 2008;27:377-83. (PMID: 18398382)

103. Burgner D, Davila S, Breunis WB, Ng SB, Li Y, Bonnard C, Ling L, Wright VJ, Odam M, Shimizu C, Burns JC, Levin M, Kuijpers TW, Hibberd ML for the International Kawasaki Disease Genetics Consortium. A genome-wide association study identifies novel and functionally related susceptibility loci for Kawasaki disease. PloS Genetics. 2009;5(1):e1000319. (PMID: 19132087)

104. Kanegaye JT, Wilder MS, Molkara D, Frazer J, Pancheri J, Tremoulet AH, Watson VE, Best BM, Burns JC. Recognition of a Kawasaki Disease Shock Syndrome. Pediatrics. 2009; 123:e783-789. (PMID: 19403470)

105. Wang S, Best BM, Burns JC. Periungual desquamation in patients with Kawasaki Disease. Pediatr Infec Dis J. 2009;28:538-539. (PMID: 19483521)

106. Shike H, Kanegaye JT, Best BM, Pancheri J, Burns JC. Pyuria associated with acute Kawasaki disease and fever from other illnesses. Pediatr Infec Dis J. 2009;28:440-443. (PMID: 19319019)

107. Kushner HI, Macnee RP, Burns JC. Kawasaki Disease in India: Increasing awareness or increased incidence? Perspectives in Biol and Medicine. 2009;52: 17-29. (PMID: 19168941)

108. Son MB, Gauvreau K, Burns JC, Corinaldesi E, Tremoulet AH, Watson VE, Baker A, Fulton DR, Sundel RP, Newburger JW. Infliximab for IVIG resistance in Kawasaki disease: A retrospective two-center study. J Pediatr. 2011 Apr;158(4):644-649.e1. (PMID: 21129756)

109. Franco A, Shimizu C, Griffith PE, Watson VE, Burns JC. Characterization of the peripheral T-cell repertoire in acute Kawasaki disease. Autoimmunity.2010;43(4):317-24.

110. Popper SJ, Watson VE, Shimizu C, Kanegaye JT, Burns JC, Relman DA. Gene transcript abundance profiles distinguish Kawasaki disease from adenovirus infection . J Inf Dis 2009;200:657-666. (PMID: 20166878)

111. He W, Kulkarni H, Castiblanco J, Shimizu C, Aluyen U, Maldonado R, Carrillo A, Griffin M, Lipsitt A, Beachy L, Shostakovich-Koretskaya L, Mangano A, Sen L, Nibbs RJB, Tiemessen CT, Bolivar H, Bamshad MJ, Clark RA, Burns JC, Dolan MJ, Ahuja SK. CCL3L1 and HIV/AIDS susceptibility. Nature Medicine. 2009 Oct:15(10): 1117-1120. (PMID: 19812563)

112. Gordon JB, Kahn A, Burns JC. When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood. JACC 2009;54:1911-1920. (PMID: 19909870)

113. Yellen E, Gauvreau K, Takahashi M, Burns JC, Shulman S, Baker AL, Innocentini N, Zambetti C, Pancheri J, Ostrow A, Frazer JR, Sundel RP, Fulton DR, Newburger JW. Performance of 2004 American Heart Association Recommendations for Treatment of Kawasaki Disease: A Multi-Center Retrospective Review of Patients with Coronary Artery Aneurysms. Pediatrics. 2010 Feb;125(2):e234-41. (PMID: 20100771)

114. Fury W, Tremoulet AH, Watson VE, Best BA, Shimizu C, Hamilton J, Kanegaye JT, Wei Y, Kao C, Burns JC. Transcript abundance patterns in Kawasaki disease patients

Jane C. Burns, M.D.

16

with IVIG-resistance. Human Immunology 2010;7:865-873. (PMID: 20600450) 115. Shimizu C, Matsubara T, Onouchi Y, Jain S, Sun S, Nievergelt CM, Shike H, Takegawa

T, Furukawa, Akagi T, Newburger JW, Baker AL, Burgner D, Hibberd ML, Davila S, Levin M, Mamtani M, He W, Ahuja SK, Burns JC. Matrix metalloproteinases haplotypes are associated with coronary artery aneurysm formation in patients with Kawasaki disease. J Human Genetics 2010;55(12):779-84. (PMID: 20827277)

116. Mamtani M, Matsubara T, Shimizu C, Weijing He, Furukawa S, Akagi T, Onouchi Y, Hata A, Fujino A, Ahuja SK, Burns J. Association of CCR2-CCR5 haplotypes and CCL3L1 copy number with Kawasaki disease, coronary artery disease, and therapy responses in Japanese children. PloS One 2010;5:e11458. (PMID: 20628649)

117. Ling XB, Lau K, Kanegaye JT, Pan Z, Peng S, Ji J, Liu G, Sato Y, Yu TT, Whitin JC, Schilling J, Burns JC, Cohen HJ.A diagnostic algorithm combining clinical and molecular data distinguishes Kawasaki disease from other febrile illnesses. BMC Med. 2011 Dec 6;9:130. doi: 10.1186/1741-7015-9-130.PMID: 22145762

118. Shimizu C, Jain S, Lin KO, Molkara D, Frazer JR, Sun S, Baker AL, Newburger JW, Rowley AH, Shulman ST, Davila S, Hibberd ML, Burgner D, Breunis WB, Kuijpers TW, Wright VJ, Levin M, Popper SJ, Relman DA, Fury W, Lin C, Mellis S, Tremoulet AH, Burns JC. Transforming growth factor-β signaling pathway in patients with Kawasaki disease. Circulation: Cardiovascular Genetics 2011;4:16-25. (PMID: 21127203)

119. Onouchi Y, Ozaki K, Burns JC, Shimizu C, Hamada H, Honda T, Terai M, Honda A, Takeuchi T, Shibuta S, Suenaga T, Suzuki H, Higashi K, Yasukawa K, Suzuki Y, Sasago K, Kemmostu Y, Takatsuki S, Saji T, Yoshikawa T, Nagai T, Hamamoto K, Kishi F, Ouchi K, Sato Y, Yashiro M, Nakaumura Y, Wakui K, Fukuchima Y, Fujino A, Tsunoda T, Kawasaki T, Hata A, Nakamura Y, Tanaka T. Common variants in CASP3 confer susceptibility to Kawasaki disease. Hum Mol Genet. 2010;15;19(14):2898-906. (PMID: 20423928)

120. Swanson C, Burns JC, Peterson B. Low plasma d-dimer concentration predicts the absence of traumatic brain injury in children. J Trauma. 2010 May;68(5):1072-7. (PMID: 20453761)

121. Park JL, Ling XB, Nguyen KD, Carroll T, Milojevic D, Lau K Macaubas C, Lee T, Sandborg C, Kanegaye JT, Burns JC, Schilling J, Mellins ED. Plasma protein profiles distinguish systemic juvenile idiopathic arthritis from other inflammatory conditions. Proteomics. 2010 Dec;10(24):4415-30. (PMID: 21136595)

122. Ling XB, Lau K, Deshpande C, Park JL, Milojevic D, Xiao C, Lopez-Avila V, Burns JC, Cohen H, Schilling J, Mellins ED. Urine peptidomic and targeted plasma protein analyses suggest SJIA urine peptide biomarkers an outcome of inflammation-driven effects on catabolic pathways operating at multiple sites. Clin Proteomics. 2010;6(4):175-193. (PMID: 21124648)

123. Zanetti M, Burns JC, Franco A. Endoplasmic reticulum stress drives regulatory T-cell differentiation in Kawasaki disease. Cellular Immunology. 2010;266(1):1-6. (PMID: 20951371)

124. Sato YZ, Molkara DP, Tremoulet AH, Daniels LB, Shimizu C, Kanegaye JT, Watson

Jane C. Burns, M.D.

17

VE, Best BM, Snider JV, Frazer JR, Maisel A, Burns JC. Cardiovascular biomarkers in acute Kawasaki disease. Int J Cardiol. 2013;164(1):58-63. (PMID: 21777987)

125. Hong DK, Tremoulet AH, Burns JC, Lewis DB. Cross-Reactive Neutralizing Antibody against Pandemic 2009 H1N1 Influenza A Virus in Intravenous Immunoglobulin Preparations. Ped Inf Dis J. 2011 Jan;30(1):67-9. (PMID: 20724956)

126. Khor CC, Davila S, Shimizu C, Sheng S, Matsubara T, Suzuki Y, Newburger JW, Baker A, Burgner D, Breunis W, Kuijpers T, Wright VJ, Levin M, Hibberd ML, Burns JC. Genome wide linkage and association mapping identify susceptibility alleles in ABCC4 for Kawasaki disease. Journal of Medical Genetics 2011;48:467-472. (PMID: 21571869)

127. Singh S, Aulakh R, Bhalla AK, Suri D, Manojkumar R, Narula N, Burns JC. Is Kawasaki disease incidence rising in Chandigarh, North India? Arch Dis Child. 2011 ;96(2):137-40. (PMID: 20923951)

128. Ling BX, Lau K, Kanegaye JT, Pan Z, Peng S, Ji J, Liu G, Sato Y, Yu TT, Whitin JC, Schilling J, Burns JC, Cohen HJ. A diagnostic algorithm combining clinical and molecular data distinguishes Kawasaki disease from other febrile illnesses. BMC Med 2011 Dec 6;9:130. (PMID: 22145762)

129. Tremoulet AH, Devera G, Best BM, Jimenez-Fernandez S, Sun X, Jain S, Burns JC. Increased incidence and severity of Kawasaki disease among Filipino-Americans in San Diego County. Pediatr Inf Dis J 2011 Oct;30(10):909-11. (PMID: 21552184)

130. Broderick L, Tremoulet AH, Burns JC, Bastian JF, Hoffman HM. Recurrent fever syndromes in patients after recovery from Kawasaki syndrome. Pediatrics 2011 Feb;127(2):e489-93. (PMID: 21220401)

131. Sengupta D, Kahn AM, Burns JC, Sankaran S, Shadden S, Marsden AL. Modeling of hemodynamics in coronary artery aneurysms caused by Kawasaki disease. Biomech Model Mechanobiol. 2012 Jul;11(6):915-32. (PMID: 22120599)

132. Kottek A, Shimizu C, Burns JC. Kawasaki disease in monozygotic twins. Ped Inf Dis J. 2011 Dec;30(12):1114-6. (PMID: 21796015)

133. Ling XB, Kanegaye JT, Sato Y, Ji J, Burns JC, Cohen HJ. A data-driven system for point-of-care differentiation of Kawasaki disease from other febrile illnesses. J Pediatr. 2013 Jan;162(1):183-188. (PMID: 22819274)

134. Khor CC, Davila S, Breunis WB, Lee YC, Shimizu C, Wright VJ, Yeung RSM, Tan DEK, Wang JJ, Wong TY, Mitchell P, Cimaz R, Dahdah N, Cheung YF, Huang GY, Yang W, Park IS, Lee JK, Wu JR, Levin M, Burns JC, Burgner, Kuijpers TW, Hibberd ML. Genome-wide association study in five independent cohorts identifies FCGR2A as a susceptibility factor for Kawasaki disease. Nature Genetics. 2011 Nov 13;43(12):1241-6. (PMID: 22081228)

135. Shimizu C, Oharaseki T, Takahashi K, Kottek A, Franco A, Burns JC. The role of TGF-β and myofibroblasts in the arteritis of Kawasaki disease. Human Pathology 2013;44:189-198. (PMID: 22955109)

136. Tremoulet AH, Chandrasekar D, Jain S, Sun X, Burns JC. Dynamic changes in clinical laboratory values in Kawasaki Disease. Pediatr Inf Dis J. 2011 Dec;30(12):1022-6. (PMID: 21817952)

Jane C. Burns, M.D.

18

137. Breunis WB, Davila S, Shimizu C, Oharaseki T, Takahashi K, van Houdt M, Khor CC, Wright VJ, Levin M, Burns JC, Burgner D, Hibberd ML, Kuijpers TW. Disruption of vascular homeostasis in Kawasaki Disease patients: Involvement of vascular endothelial growth factor and angiopoietins. Arth Rheum. 2012 Jan;64(1):306-15. (PMID: 21905000)

138. Rodo X, Ballester J, Cayan D, Melish ME, Nakamura Y, Uehara R, Burns JC. Association of Kawasaki disease with tropospheric wind patterns. Science Reports. 2011;1:152. (PMID: 22355668)

139. Kahn AM, Budoff MJ, Daniels LB, Fernandez S, Cox AS, Gordon JB, Burns JC. Calcium scoring in patients with a history of Kawasaki disease. JACC Cardiovasc Imaging. 2012 Mar;5(3):264-72. (PMID: 22421171)

140. Daniels LB, Tjajadi MS, Walford HH, Fernandez S, Trofimenko V, Fick DB, Phan H-AL, Linz PE, Nayak K, Kahn AM, Burns JC, Gordon JB. Prevalence of Kawasaki Disease in young adults with suspected myocardial ischemia. Circulation. 2012 May 22;125(20):2447-53. (PMID: 22595319)

141. Tremoulet AH, Pancoast P, Franco A, Bujold M, Shimizu C, Onouchi Y, Tamamoto A, Erdem G, Dodd D, Burns JC. Calcineurin inhibitor treatment of IVIG-resistant Kawasaki disease. J Pediatr. 2012 Sep;161(3):506-512.e1. (PMID: 22484354)

142. Broderick L Tremoulet AH, Burns JC, Hoffman HM. Prolonged urticarial and fever in a toddler. Allergy Asthma Proc. 2012 May;33(3):297-301. (PMID: 22584197)

143. Onouchi Y, Ozaki K, Burns JC, Shimizu C, Terai M, Hamada H, Honda T, Suzuki H, Suenaga T, Takeuchi T, Yoshikawa N, Suzuki Y, Yasukawa K, Ebata R, Higashi K, Saji T, Kemmotsu Y, Takatsuki S, Ouchi K, Kishi F, Yoshikawa T, Nagai T, Hamamoto K, Sato Y, Honda A, Kobayashi H, Sato J, Shibuta S, Miyawaki M, Oishi K, Yamaga H, Aoyagi N, Iwahashi S, Miyashita R, Murata Y, Sasago K, Takahashi A, Kamatani N, Kubo M, Tsunoda T, Hata A, Nakamura Y, Tanaka T; Japan Kawasaki Disease Genome Consortium; US Kawasaki Disease Genetics Consortium. A genome wide association study identifies three new risk loci for Kawasaki disease. Nat Genet. 2012 Mar 25;44(5):517-21. (PMID: 22446962)

144. Kanegaye JT, Van Cott E, Tremoulet AH, Salgado A, Shimizu C, Kruk P, Hauschildt J, Sun X, Jain S, Burns JC. Differentiating lymph-node-first presentation of Kawasaki disease from bacterial lymphadenitis. J Pediatr. 2013;162(6):1259-63. (PMID: 23305955)

145. Risk SRY, El Said G, Daniels LB, El Said H, Sorour KA, Gharib S, Burns JC, Gordon JB. Acute myocardial ischemia in Egyptian adults secondary to missed Kawasaki disease in childhood. Am J Cardiol. 2015 Feb 15;115(4):423-7. doi: 10.1016/j.amjcard.2014.11.024. Epub 2014 Nov 29.PMID: 25555655

146. Ballester J, Burns JC, Cayan D, Nakamura Y, Uehara R, Rodo, X. Kawasaki Disease and ENSO-driven wind circulation. Geophysical Research Letters. 2013.40:1-6.

147. Bratinscak A, Purohit PJ, Tremoulet AH, Sang N, Pour Molkara D, Frazer JR, Dyar D, Bush RA, Sim JY, Burns JC, Melish MA, Reddy VD. Coronary artery dilation in acute Kawasaki disease and acute illnesses associated with fever. Ped Inf Dis J. 2012;31: 924–

Jane C. Burns, M.D.

19

926. (PMID: 22673140) 148. Salo E, Griffiths EP, Farstad T, Schiller B, Nakamura Y, Yashiro M, Uehara R, Best BM,

Burns JC. Incidence of Kawasaki disease in northern European countries. Pediatr Int. 2012 Dec;54(6):770-2. (PMID: 22726311)

149. Burns JC, Herzog L, Fabri O, Tremoulet AH, Rodo X, Uehara R, Burgner D, Bainto E Pierce D, Tyree M, Cayan D for the Kawasaki Disease Global Climate Consortium. Seasonality of Kawasaki disease: A global perspective. PLoS One 2013 Sep 18;8(9):e74529. doi: 10.1371/journal.pone.0074529. (PMID: 24058585)

150. Sengupta D, Kahn AM, Shirinsky O, Burns JC, Marsden AL. Thrombotic risk stratification using computational modeling in patients with coronary artery aneurysms following Kawasaki disease. Biomech Model Mechanobiol. 2014 Apr 11. [Epub ahead of print] (PMID: 24722951)

151. Shimizu C, Kim J, Stepanowsky P, Trinh C, Lau HD, Arker J, Chen C, Kanegaye JT, Tremoulet AH, Ohno-Machado L, Burns JC. Differential expression of microRNAs in children with Kawasaki disease. PLoS One 2013;8(3):e58159. (PMID: 23483985)

152. Franco A, Tuoma R, Song Y, Shimizu C, Tremoulet AH, Kanegaye J, Burns JC. Specificity of regulatory T cells that modulate vascular inflammation. Autoimmunity. 2014;47(2):95-104. (PMID: 24490882)

153. Padler-Karavani V, Tremoulet AH, Yu H, Chen X, Burns JC, Varki A. A Simple Method For Assessment Of Human Anti-Neu5Gc Antibodies Applied to Kawasaki Disease. PLoS One. 2013;8(3):e58443. (PMID: 23520510)

154. Ogata S, Tremoulet AH, Sato Y, Ueda K, Shimizu C, Sun X, Jain S, Silverstein L, Baker AL, Tanaka N, Ogihara Y, Ikehara S, Takatsuki S, Sakamoto N, Kobayashi T, Fuse S, Matsubara T, Ishii M, Saji T, Newburger JW, Burns JC. Coronary artery outcomes among children with Kawasaki disease in the United States and Japan. Int J Cardiol. 2013 Oct 9;168(4):3825-8 (PMID: 23849968)

155. Lin J, Liu V, Sato YZ, Jiminez-Fernandez S, Pourfarzib R, Winegar DA, Tremoulet AH, Gordon JB, Daniels LB, Burns JC. Lipoprotein particle concentrations in children and adults following Kawasaki disease. J Pediatr. 2014 Oct;165(4):727-31 (PMID: 25039043)

156. Leuin SC, Shanbhag S, Lago D, Sato Y, Sun X, Jain S, Burns JC, Tremoulet AH. Hoarseness as a presenting symptom in children with Kawasaki disease. Ped Inf Dis J. 2013;32(12):1392-4. (PMID: 23811742)

157. Hoang LT, Shimizu C, Ling L, Naim A, Khor CC, Tremoulet AH, Kanegaye JT, Hibberd ML, Burns JC. Global gene expression profiling identifies new therapeutic targets in acute KD. Genome Medicine. 2014, 6:541. DOI: 10.1186/s13073-014-0102-6

158. Tremoulet AH, Jain S, Jaggi P, Jiminez-Fernandez S, Pancheri JM, Sun X, Kanegaye JT, Kovalchin JP, Printz B, Ramilo O, Burns JC. Phase III randomized, double-blind, placebo-controlled trial of infliximab for intensification of primary therapy for Kawasaki disease. Lancet. 2014 May 17;383(9930):1731-8. (PMID: 24572997)

159. Gordon CT, Jiminez-Fernandez, Daniels LB, Kahn A, Shimizu C, Burns JC, Gordon JB. Management and outcome of pregnancy in women with a history of Kawasaki disease.

Jane C. Burns, M.D.

20

Brit J Obs Gyn. 2014;121(11):1431-8. (PMID: 24597833) 160. Chang CJ, Kuo HC, Chang JS, Lee JK, Tsai FJ, Khor CC, Chang LC, Chen SP, Ko TM,

Liu YM, Chen YJ, Hong YM, Jang GY, Hibberd ML, Kuijpers T, Burgner D, Levin M, Burns JC, Davila S, Chen YT, Chen CH, Wu JY, Lee YC and the International Kawasaki Disease Genetics Consortium, Korean Kawasaki Disease Genetics Consortium, Taiwan Kawasaki Disease Genetics Consortium. Replication and meta-analysis of GWAS identified susceptibility loci in Kawasaki disease confirm the importance of B lymphoid tyrosine kinase (BLK) in disease susceptibility. PLoS One. 2013 Aug 30;8(8):e72037. doi: 10.1371/journal.pone.0072037. (PMID: 24023612)

161. Tremoulet AH, Dutkowski J, Jin B, Jain S, Sun X, Kanegaye JT, SatoY, Ji J, Ling XB, Cohen H, Burns JC. Novel data-mining approach identifies biomarkers for diagnosis of Kawasaki disease. Pediatr Res.2015 Nov;78(5):547-53. doi: 10.1038/pr.2015.137. Epub 2015 Aug 3. (PMID: 26237629)

162. Gordon JB, Daniels LK, Kahn A, Jiminez-Fernandez S, Shimizu C, Vejar M, Fujito N, Burns JC. The spectrum of cardiovascular lesions requiring intervention in young adults after Kawasaki disease. JACC Cardiovasc Interv. 2016 Apr 11;9(7):687-96. (PMID:27056307)

163. Burns JC, Song Y, Bujold M, Shimizu C, Kanegaye JT, Tremoulet AH, Franco A. Immune-monitoring in Kawasaki disease patients treated with infliximab and intravenous immunoglobulin. Clinical and Experimental Immunology. 2013;174:337-344 (PMID: 23901839)

164. Lia Z, Chaoa TC, Changa K-Y, Lina N, Patila VS, Shimizu C, Head SR, Burns JC, Rana TM. The long noncoding RNA THRIL regulates TNFα expression through its interaction with hnRNPL. PNAS. 2014 Jan 21;111(3):1002-7. (PMID: 24371310)

165. Kung E, Kahn AM, Burns JC, Marsden A. In vitro validation of patient-specific hemodynamic simulations in coronary aneurysms caused by Kawasaki disease. Cardiovasc Eng Technol. 2014 Jun 1;5(2):189-201. (PMID: 25050140)

166. Rodó X, Curcoll R, Robinson M, Ballester J, Burns JC, Cayan DR, Lipkin WI, Williams BL, Couto-Rodriguez M, Nakamura Y, Uehara R, Tanimoto H, Morguí JA. Tropospheric winds from northeastern China carry the etiologic agent of Kawasaki disease from its source to Japan. Proc Natl Acad Sci U S A. 2014;111(22):7952-7. doi: 10.1073/pnas.1400380111. (PMID: 24843117)

167. Ogata S, Shimizu C, Franco A, Touma R, Kanegaye JT, Choudhury BP, Naidu NN, Kanda Y, Hoang YT, Hibberd ML, Tremoulet AH, Varik A, Burns JC. Treatment responses in Kawasaki disease are associated with sialylation levels of endogenous but not therapeutic intravenous Immunoglobulin G. PLoS ONE.2013;8(12):e81448. (PMID: 24324693)

168. Ohno-Machado L, Agha Z, Bell DS, Dahm L, Day ME, Doctor JN, Gabriel D, Kahlon MK, Kim KK, Hogarth M, Matheny ME, Meeker D, Nebeker JR; the pSCANNER team. pSCANNER: patient-centered Scalable National Network for Effectiveness Research. J

Jane C. Burns, M.D.

21

Am Med Inform Assoc. 2014 Apr 29. doi: 10.1136/amiajnl-2014-002751. [Epub ahead of print] (PMID: 24780722)

169. Shimizu C, Sood A, Lau HD, Oharaseki T, Takahashi K, Krous, HF, Campman S, Burns JC. Cardiovascular pathology in two young adults with sudden death attributed to Kawasaki Disease in childhood. Cardiovasc Pathol. 2015 Feb 24. pii: S1054-8807(15)00022-8. [Epub ahead of print] (PMID: 25791439)

170. Lee A, Shimizu C, Oharaseki T, Takahashi K, Daniels LB, Adamson R, Dembitsky W, Gordon JB, Burns JC. Role of TGFβ signaling in remodeling of non-coronary artery aneurysms in Kawasaki disease. Pediatr Dev Pathol. 2015 Jul-Aug;18(4):310-7. doi: 10.2350/14-12-1588-OA.1. Epub 2015 Apr 9. (PMID: 25856633)

171. Kanegaye JT, Jones JM, Burns JC, Jain S, Sun X, Jimenez-Fernandez S, Berry E, Pancheri JM, Jaggi P, Ramilo O, Tremoulet AH. Axillary, Oral, and Rectal Routes of Temperature Measurement During Treatment of Acute Kawasaki Disease. Pediatr Infect Dis J. 2015 Sep 21. [Epub ahead of print](PMID: 26398742)

172. Numano F, Shimizu C, Jiminez-Fernandez S, Vejar M, Salgado A, Tremoulet AH, Gordon JB, Burns JC, Daniels LB. Galectin-3 as a predictor of myocardial fibrosis in Kawasaki Disease. 2015 Dec 15;201:429-37. doi: 10.1016/j.ijcard.2015.07.063. Epub 2015 Jul 27. (PMID:26313861)

173. Ling L, Bulik D, Duffner J, Bosques C, Hillson J, Capila I, Shimizu C, Tremoulet A, Burns JC. High resolution molecular profiling reveals persistence of inflammation in Kawasaki disease patients with coronary artery aneurysms. Submitted.

174. Alphonse MP, Duong TT, Shimizu C, McCrindle B, Franco A, Schurmans S, Philpott D, Hibberd ML, Burns JC, Kuijpers TW, Yeung RSM. ITPKC mediates NLRP3 inflammasome activation, regulating immune activation and treatment response in Kawasaki disease. Submitted.

175. Krakowski AC, Kim SS, Burns JC. Transient lingual papillitis associated with confirmed herpes simplex virus 1 in a patient with Kawasaki disease. Pediatr Dermatol. 2014 Nov-Dec;31(6):e124-5. (PMID: 25424222)

176. Burns JC, Touma R, Song Y, Padilla RL, Tremoulet AH, Sidney J, Sette A, Franco A. Fine specificities of natural regulatory T cells after IVIG therapy in patients with Kawasaki disease. Autoimmunity. 2015 Mar 30:1-8. (PMID: 25822882)

177. Numano F, Shimizu C, Tremoulet AH, Dyar D, Burns JC, Printz BF. Right ventricular dysfunction and pulmonary artery dilation in acute Kawasaki disease. Pediatr Cardiol. Dec 17 [Epub ahead of print]. (PMID: 26681305)

178. Jaggi P, Wang W, Dvorchik I, Printz B, Berry E, Kovalchin JP, Texter K, Ramilo O, Burns JC, Tremoulet AH. Patterns of Fever in Children After Primary Treatment for Kawasaki Disease. Pediatr Infect Dis J. 2015 Sep 7. [Epub ahead of print] (PMID:26353031)

179. Tremoulet AH, Sonia J, Kim S, Newburger JW, Arditi M, Franco A, Burns JC. Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities. In press.

Jane C. Burns, M.D.

22

180. Hao S, Jin B, Tan Z Li Z, Ji J, Hu G, Kanegaye JT, Tremoulet AH, Burns JC, Cohen HJ, Ling XB. A decision-support tool for differentiation of Kawasaki disease from other febrile illnesses. In revision, J Pediatr.

181. Shimizu C, Eleftherohorinou H, Wright V, Kim J, Alphonse M, Cimaz R, Burgner D, Dahdah N, Hoang LT, Khor CC, Salgado A, Tremoulet A, Davila S, Kuijpers TW, Hibberd ML, Onouchi Y, Yeung RSM, Coin LJM, Levin M, Burns JC. Genetic variation in the calcium signaling pathway influences susceptibility to Kawasaki disease and aneurysm formation. Submitted.

182. Connelly MA, Shimizu C, Shalauroval I, Winegar DA, Pourfarzib R, Otvos JD, Kanegaye JT, Tremoulet AH, Burns JC. Elevated GlycA and inflammation-mediated alterations in lipoprotein particle distribution in children with acute Kawasaki disease. In press, BMJ Pediatrics.

183. Friedman KG, Gauvreau K, Hamaoko-Okamoto A, Tang A, Berry E, Tremoulet A Mahavadi VS, Baker A, deFerranti SD, Fulton DR, Burns JC, Newburger JW. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in US Population. Submitted.

184. Wright VJ, Herberg JA, Kaforou M, Eleftherohorinou J, Shimizu C Shailes H Barendregt AM, Tremoulet AH, Kanegaye JT, Coin LJM, Glode MP, Hibberd M, Kuijpers T, Hoggart C, Burns JC, Levin M. Diagnosis of Kawasaki disease using blood RNA expression signatures. Submitted.

185. Doan S, Maehara CK, Chapporro JD, Lu S, Lui R Graham A, Berry E, Hus C-N, Kanegaye JT, Lloyd DD, Ohno-Machodo L, Burns JC, Tremoulet AH. Building a Natural Language Processing Tool to Identify Patients with High Clinical Suspicion for Kawasaki Disease from Emergency Department Notes. In press, Acad Emerg. Med.

186. Haddock ES, Calame A, Shimizu C, Tremoulet AH, Burns JC, Tome WL. Psoriasiform Eruptions in the Setting of Kawasaki Disease: A Distinct Phenotype. In press, Journal of the American Academy of Dermatology.

187. de Ferranti SD, Gauvreau KK, Berry E, Tang A, Baker A, Fulton D, Friedman KG, Tremoulet AH, Burns JC, Newburger JW. Investigating the Added Value of Follow-up Echocardiography in Kawasaki Disease with Initially Normal Coronary Arteries. Submitted.

188. He M, Chen Z, Martin M, Zhang J, Woo B, Tremoulet AH, Shimizu C, Burns JC, Shyy JY-J. miR-483 Targeting of CTGF Suppresses Endothelial-to-Mesenchymal Transition: Therapeutic Implications in Kawasaki Disease. Submitted.

189. Singhal M, Singh S, Guptal P, Sharma A, Khandelwall N, Burns JC. Low-dose computed tomography coronary angiography for evaluation of children with Kawasaki disease. Submitted.

190. Grande Gutierrez N, Shrinsky O, Gagarina NV, Lyskina GA, Fukuzawa R, Ogawa S, Burns JC, Marsden AL, Kahn AM. Assessment of Coronary Artery Aneurysms Caused By Kawasaki Disease Using Transluminal Attenuation Gradient Analysis of CT Angiograms. Submitted.

191. Zeft AS, Burns JC, Yeung RS, McCrindle BW, Newburger JW, Dominguez SR, Shulman

Jane C. Burns, M.D.

23

ST, Yoon J, Twede H, Mix C, Pope AC. Kawasaki Disease and exposure to fine particulate air pollution. Submitted.

192. Li Z, Tan Z, Hao S, Jin B, Hu G, Liu X Zhang J, Jin H, Kanegaye JT, Tremoulet AH, Burns JC, Wu J, Cohen HJ, Ling XB. Urinary colorimetric sensor array and algorithm to distinguish Kawasaki disease from other febrile illnesses. PLoS One. 2016 Feb 9;11(2):e0146733. (PMID:26859297)

B. Invited reviews, editorials, books and monographs

1. Burns JC, Todd JK: "Kawasaki Syndrome" IN: Current Therapy of Infectious Diseases.

Kass E, Platt R (eds). C.V. Mosby, St. Louis, 1984 and 1989. 2. Smith LS, Newburger JW, Burns JC: Kawasaki Disease and the Eye. Ped. Inf. Dis. J.

8:116-118, 1989. 3. Burns JC, Newburger JW: "Kawasaki Syndrome" IN: Infectious Diseases in Medicine

and Surgery. Gorbach S, Bartlett J, Blacklow N (eds). W.B.Saunders, Philadelphia, PA,1370-1374, 1992.

4. Newburger JW, Burns JC: "Kawasaki Syndrome" in Cardiology Clinics: Update in Pediatric Cardiology 7:453-467, l989.

5. Burns JC: "Kawasaki Disease" IN: Current Opinion in Pediatrics. Nathan DG (ed). 1:13-15, 1989.

6. Consensus statement by participants in the Third International Kawasaki Disease Symposium, Tokyo, Japan. Management of Kawasaki syndrome. Ped. Inf. Dis. 8:663-665, l989.

7. Yee J-K, Friedmann T, Burns JC: Generation of high-titer pseudotyped retroviral vectors with very broad host range. Methods in Cell Biology 43:99-112, 1994

8. Burns JC and Matsubara T. Kawasaki Disease: Recent advances. Trends in Cardiovascular Medicine 5:3-7, 1995.

9. Shimizu H and Burns JC. Extraction of nucleic acids: sample preparation from paraffin-embedded tissues. In PCR Strategies, Eds. M. Innis, D. Gelfand, and J. Sninsky, Academic Press, pp.32-38, 1995.

10. Burns JC, Glode MP, Capparelli E, Brown JA, Newburger JW and the US/Canadian Kawasaki Syndrome Study Group. Intravenous Gamma globulin treatment in Kawasaki syndrome: Are all brands equal? In Kawasaki Disease: Proceedings of the 5th International Kawasaki Disease Symposium, Fukuoka, Japan, May 1995, Ed. H Kato, Elsevier Press, pp.296-300, 1995.

11. Burns JC, Yee JK, Yu AL. Methods for producing high titer, pantropic retroviral vectors for gene transfer into leukemic T cells. In Methods in Molecular Medicine, Gene Therapy Protocols, Ed. P. Robbins, Humana Press Inc., Totowa, NJ, pp.213-220, 1996.

12. Carlson JO, Afanasiev BN, Higgs S, Matsubara T, Burns JC. Viral transducing vectors for mosquitoes. In Molecular Biology of Insect Disease Vectors: A methods manual. Ed. Crampton JM, Beard CB, Louis C., Chapman and Hall, London, UK. 1996.

Jane C. Burns, M.D.

24

13. Chen TT, Lu J-K, Shamblott MJ, Cheng CM, Lin C-M, Burns JC, Reimschuessel R, Chatakondi N, Dunham RA. Transgenic fish: Ideal models for basic research and biotechnological applications. In Molecular Zoology Ed. Ferraris JD and Palumbi SR, Wiley-Liss, New York, pp.401-430, 1996.

14. Tsonis PA, del Rio-Tsonis K, Wallace JL, Burns JC, Hofmann MC, Millan JL, Washabaugh CH. Can insights into urodele limb regeneration be achieved with cell cultures and retroviruses? Int. J. Dev. Biol. 40: 813-816, 1996.

15. Burns JC. Vector for vectors: New approaches to disease control with pantropic retroviral vectors. Proc. Mosq. and Vector Control Assoc. of CA 64:33-35, 1996.

16. Mason WH and Burns JC. Kawasaki Disease: Clinical presentation of Kawasaki disease. In Progress in Pediatric Cardiology, 6:193-201, 1997.

17. Burns JC and Glode MP. "Kawasaki Disease" in Pediatric Infectious Disease, Vol. XI, Atlas of Infectious Diseases, Catherine Wilfert, Volume Editor, Current Medicine Inc., Phil PA. Chapter 10, 1999.

18. Newburger JW and Burns JC. Kawasaki Disease. Trends in Vascular Medicine, 4: 187-202, 1999

19. Burns JC. Pantropic retroviral vectors for insect gene transfer. In "Insect Transgenesis: Methods and Applications". AM Handler and AA James, editors, CRC Press, Boca Raton, FL, 2000, pp126-136.

20. McCrindle BW, Shulman ST, Burns JC, Kato H, Gersony WM, Newburger JW. Summary and abstracts of the Sixth Inernational Kawasaki Disease Symposium. Ped Res 47:544-569, 2000.

21. Burns JC. Kawasaki disease. Advances in Pediatrics. 48:157-77, 2001. 22. Burns JC. Kawasaki disease: The mystery continues. Minerva Pediatrics, 54:2002. 23. Burns JC. Commentary: Translation of Dr. Tomisaku Kawasaki's original report of fifty

patients in 1967. Pediatr Infect Dis J 2002;21:993-995. 24. Burns JC and Glode MP. Kawasaki Syndrome. Invited Seminar Lancet 2004;364: 533-

543. 25. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman

ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA; Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease; Council on Cardiovascular Disease in the Young; American Heart Association; American Academy of Pediatrics. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110:2747-71.

26. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA

Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on

Jane C. Burns, M.D.

25

Rheumatic Fever, Endocarditis, and Kawasaki Disease, American Heart Association: Circulation 2005;111:e394-434.

27. Burns JC. “Kawasaki Disease” in The Endothelium: A Comprehensive Reference. Ed. William C. Aird, Cambridge Univ. Press. 2006.

28. Burns JC. “Kawasaki Disease” in Head and Neck Manifestations of Systemic Disease. Ed. Jeffrey P. Harris. Informa Healthcare, NYC, NY.2007:117-124.

29. Kushner HF, Macnee R, Burns JC. Impressions of Kawasaki Disease in India. Editorial. Indian Pediatrics 2006;43:939-942

30. Burns JC. S100 proteins in the pathogenesis of Kawasaki disease. Editorial.JACC 2006;48:1265-1267.

31. Burns JC. Revisiting steroids in the primary treatment of acute Kawasaki Disease. Editorial. J Pediatr 2006;149:291-292.

32. Burns JC. Invited Perspective: The riddle of Kawasaki disease. NEJM 2007;356:659-661. 33. Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, Bolger A,

Cabell CH, Takahashi M, Baltimore RS, Newburger JW, Strom BL, Tani LY, Gerber M, Bonow RO, Pallasch T, Shulman ST, Rowley AH, Burns JC, Ferrieri P, Gardner T, Goff D, Durack DT. Prevention of infective endocarditis: Guidelines from the American Heart Association: A guideline from the American Heart Association Rheumatic Fever, Endocarditis and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. J Am Dent Assoc. 2007 Jun;138(6):739-60.

34. Burns JC. Pulsed corticosteroids of no benefit in Kawasaki disease. J Pediatr (editorial) 2007;151:101-102.

35. Burns JC. Kawasaki disease update. Invited review, Indian J Pediatr. 2009;76:71-76. 36. Burns JC. “Kawasaki disease”. In Rheumatology, 5th ed. 2010, 6th ed. 2014. 37. Burns, JC and Kanegaye JT. Fever and red eyes. In: Challenging Cases in Pediatric

Ophthalmology. Robbins SL, Baber JA and Granet DB, eds. American Academy of Pediatrics. 2012. Elk Grove Village, IL.

38. Burns, JC. Of Mice and Children: Lessons from a Kawasaki Mouse Model. Circulation. (editorial) 2012 Feb 23.

39. Burns JC. Finding Kawasaki disease. Invited Commentary. Annals of Pediatric Cardiology. 2012;5:133-134.

40. Daniels LB, Gordon JB, Burns JC. Kawasaki Disease: Late Cardiovascular Sequelae. Curr Opin Cardiol. 2012 Nov;27(6):572-7. Invited Review. (PMID: 23075819)

41. Burns JC. “Kawasaki disease”. In Vasculitis, Oxford University Press. 42. Burns JC and Newburger JW. Genetic insights into the pathogenesis of Kawasaki

disease. Circ Cardiovasc Genet. (editorial) 2012 Jun;5(3):277-8. (PMID: 22715279) 43. Burns JC and Daniels LB. Assessing vascular health after Kawasaki disease: A

cautionary tale. J Am Coll Cardiol. (editorial) 2013 Sep 17;62(12):1122-3. (PMID: 23850904)

44. Burns JC. Mandel Infectious Diseases. “Kawasaki Disease”. In press.

Jane C. Burns, M.D.

26

45. Levin M, Burns JC, Gordon JB. (editorial). Warfarin plus aspirin or aspirin alone for patients with giant coronary artery aneurysms secondary to Kawasaki disease. In press. Warfarin plus Aspirin or Aspirin Alone for Patients with Giant Coronary Artery Aneurysms Secondary to Kawasaki Disease? Cardiology. 2014 Oct 7;129(3):174-177. (PMID: 25300244)

46. Dietz SM, Tacke CE, Kuipers IM, Wiegman A, de Winter RJ, Burns JC, Gordon JB, Groenink M, Kuijpers TW. Cardiovascular imaging in children and adults following Kawasaki disease. Insights Imaging 2015 Dec;6(6):697-705. (PMID: 26210915)

47. Burns JC, Franco A. The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease. Expert Rev Clin Immunol. 2015 Jul;11(7):819-25. (PMID: 26099344)

48. Daniels LB, Burns JC. Circ J. 2015 Oct 23;79(11):2299-305. doi: 10.1253/circj.CJ-15-0996. Epub 2015 Oct 15 (PMID:26467080)

49. Newburger JW, Takahashi M, Burns JC. Review Topic of the Week: Kawasaki disease. In press, JACC.

C. Abstracts and Presentations (only recorded up to 2000)

1. Burns JC, Glode MP, Clarke SH, Hathaway WE: Evidence for coagulopathy and platelet

activation in Kawasaki Syndrome. Presented at the Western Society of Pediatric Research, Carmel, California, February 1983 and at the Society for Pediatric Research, Washington, D.C., May 1983.

2. Burns JC, Glode MP: "Kawasaki Syndrome." Presented at 8th Uniformed Services Dermatology Seminar, Colorado Springs, May 1983.

3. Burns JC, Hendry RM, Ho JC, Fernie B and McIntosh K: Antigen-specific secretory antibody (Ab) response following respiratory syncytial virus (RSV) infection in infants. Presented at the Society for Pediatric Research, San Francisco, CA, May 1984.

4. Glode MP, Burns JC, Joffe L, Arlian L, Adinoff A, Leung DYM: Role of house dust mites in Kawasaki Syndrome. Presented at the Society for Pediatric Research, San Francisco, CA, May 1984.

5. Leung DYM, Burns JC, Newburger J, Rosen FS, Geha RS: Reversal of immunoregulatory abnormalities in Kawasaki Syndrome by intravenous Gamma globulin. Presented at the American Society for Clinical Investigation, May 1985.

6. Multicenter Collaborative Kawasaki Study Group. Efficacy of gamma-globulin in preventing coronary artery aneurysms in Kawasaki Syndrome. Presented at the International Congress of Cardiology, New York City, June 1985.

7. Burns JC, Hendry RM, Hendricks DA, Patterson JL, McIntosh K: Antigenic variation between Long (RSV-L) and 18537 strains of Respiratory Syncytial Virus (RSV). Presented at the American Society for Virology, Albuquerque, NM, July 1985.

8. Newburger JW, Sanders P, Burns JC, Parness IA, Beiser, AS, Colan SD: Myocardial contractility and diastolic function in Kawasaki syndrome. Presented at the American Heart Association Meetings, Dallas, TX, November 1986.

Jane C. Burns, M.D.

27

9. Hendry RM, Burns JC, Prince GA, et al: Infant sera recognize antigenically distinct strains of RSV. Presented at the American Society for Virology, Santa Barbara, CA, June 1986.

10. Brosius CL, Newburger JW, Burns JC, Hojonowski-Diaz P, Leung DYM: Association of Kawasaki Syndrome with atopic dermatitis. Presented at the Society for Pediatric Research, Los Angeles, CA, April 1987.

11. Burns JC, Geha RS, Newburger JW, Rosen FS, Walsh MM, Reinhart AL, Huang AS, Leung DYM: Reverse transcriptase activity in peripheral blood mononuclear cell cultures from patients with Kawasaki Disease. Presented at the Society for Pediatric Research, Anaheim, CA, April 1987 and at the UCLA Symposium on Human Retroviruses, Keystone, CO, 1987.

12. Leung DYM, Burns JC, Schneeberger EE, Newburger JW, Rosen FS, Huang AS, Pober JS, Geha RS: Peripheral blood mononuclear cells from patients with Kawasaki Syndrome transmit reverse transcriptase activity to human endothelial cells. Presented at the American Federation for Clinical Research, May 1987.

13. Newburger J, Burns J, Shen G, Brosius C, Loscalzo J: Altered Lipid Metabolism Following Kawasaki Syndrome. Presented at the American Heart Association Meetings, Anaheim, CA, November 1987.

14. Newburger JW, Sanders SP, Burns JC, Parness IA, Beiser AS, Colan SD: Left ventricular contractility and function in Kawasaki Syndrome: Effect of intravenous Gamma globulin. Presented at the American Heart Association Meetings, Washington, D.C., November 1988.

15. Newburger JW, Burns JC, Mendelsohn ME, Beiser AS, Loscalzo J: Plasminogen activation in Kawasaki syndrome. Presented at the American Heart Association Meetings, Washington D.C., November 1988.

16. Leung DYM, Cotran RS, Kurt-Jones EA, Burns JC, Newburger JW, Pober JS: Increased cytokine production and Jane endothelial cell activation in Kawasaki and reversal by intravenous Gamma globulin therapy. Presented at the American Federation for Clinical Research, May 1989.

17. Colan SD, Sanders SP, Parness IA, Spevak PJ, Burns JC, Newburger JW: Abnormal myocardial mechanics in Kawasaki syndrome: rapid response to gamma globulin therapy. Presented at the American Heart Association Meeting, New Orleans l989.

18. Finberg RW, Newburger JW, Burns JC: High dose intravenous globulin increases natural killer cell activity in patients with KD. Presented at the Society for Pediatric Research Meeting, Anaheim, CA, May 1990.

19. Sundel R, Loh RKS, Meyerson H, Burns JC, Newburger JW: Immunoglobulin levels in Kawasaki Disease. Presented at the Northeastern Regional Meeting of the American College of Rheumatology, New York City, May 1990 and the national meeting, Seattle, WA, October 1990.

20. Burns JC, Newburger JW for the US Multicenter KD Study Group. Epidemiological characteristics of patients referred for evaluation of possible Kawasaki Disease. Presented at the Interscience Congress for Antimicrobial Agents and Chemotherapy (ICAAC),

Jane C. Burns, M.D.

28

Atlanta, GA, October 1990. 21. Burns JC, Newburger JW for the US Multicenter KD Study Group. Clinical and

laboratory characteristics of patients referred for evaluation of possible Kawasaki disease. Presented at the Interscience Congress for Antimicrobial Agents and Chemotherapy (ICAAC), Atlanta, GA, October 1990.

22. Sundel RP, Newburger JW, Cleveland SS, Burns JC: Kawasaki disease and sensorineural hearing loss. Presented at the American College of Rheumatology, Seattle, WA, October 1990.

23. Sundel RP, Cleveland SS, Beiser A, Novak RE, Kramer S, Newburger JW, Koren G, McGill T, Harris JP, Burns JC: Audiologic profiles of children with acute Kawasaki disease. Presented at the American Otological Society Meeting, May 1991.

24. Burns JC, for the Kawasaki Disease Multicenter Hearing Loss Study Group. Sensorineural Hearing loss associated with Kawasaki Disease. Presented at the Interscience Congress for Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, IL, October 1991.

25. Burns JC, Wilson H, Glode MP, Felsburg PJ, Glickman LT, Rosen FS. Canine Pain Syndrome: A model for Kawasaki Disease. Presented at the 4th International Kawasaki Disease Symposium, Maui, HI, December 1991.

26. Sundel RP, Burns JC, Newburger JW, Gellis SE. Psoriatic rash in Kawasaki Disease. Poster presented at the 4th International Kawasaki Disease Symposium, Maui, HI, December 1991.

27. Sundel RP, Beiser AS, Baker A, Burns JC, Newburger JW. Gamma globulin retreatment in Kawasaki Disease. Presented at the 4th International Kawasaki Disease Symposium, Maui, HI, December 1991.

28. Burns JC, Bastian JF, Aziz DC, Rittenhouse J: Flow cytometric analysis of antineutrophil cytoplasmic antibodies (ANCA) in patients (PTS) with acute Kawasaki disease (KD). Poster presented at The Society for Pediatric Research, Baltimore, MD, May 1992.

29. Shimizu H, Smaron MF, McCarthy CA, Burns JC. Polymerase chain reaction for detection of measles virus. Presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Anaheim, CA, October 1992.

30. Shimizu H, Waterman SH, Stein MA, Burns JC. Polymerase chain reaction for the detection of measles virus genome in urine sediment. Presented at the Western Society for Pediatric Research, Carmel, CA, February 1993.

31. Malhotra A, Burns JC. Coronary artery disease in young adults as a sequela of Kawasaki Disease in childhood. Presented at the Western Society for Pediatric Research, Carmel CA, February 1993.

32. Burns JC, Lozinski GM, Yee J-K, Friedmann T, Yu J, Yu AL. Pseudotyped retroviral vector-mediated gene transfer into human leukemic cells. Presented at the Society of Pediatric Research, Seattle, WA, May 1994. Pediatr. Res. 35:Abs #934, 1994

33. Melish ME, Parsonett J, Marchette N, and the U.S.-Japan Multicenter Kawasaki Syndrome Study Group. Kawasaki Syndrome is not caused by toxic shock syndrome toxin-1 positive Staphylococci. Presented at the Society for Pediatric Research, Seattle,

Jane C. Burns, M.D.

29

WA, May 1994. Pediatr. Res. 35: Abs #1107, 1994. 34. Tanel RE, Kao S-Y, Coughran TM, Loeffelholz MJ, Shoaf L, Stucky ER, Burns JC.

Prospective comparison of culture vs. genome detection by PCR for the diagnosis of enteroviral meningitis in childhood. Presented at the Society for Pediatric Research, Seattle, WA, May 1994. Pediatr. Res. 35: Abs # 1175, 1994.

35. Lu JK, Burns JC, Chen TT. Retrovirus-mediated transfer and expression of transgenes in medaka (Oryzias latipes). Presented at the International Marine Biotech Congress, Norway, August 1994.

36. Yee J-K, Burns JC, Friedmann T. Pseudotyped retroviral vectors. Presented at Gene Therapy and Immunotherapy of Cancer, Ein Geti, Israel, February 1994.

37. Burns JC, Zwartkruis F, Rangini Z, Matsubara T, Yee J-K, Friedmann T, Driever W. VSV-G pseudotyped retroviral vector-mediated gene transfer in zebrafish. Presented Cold Spring Harbor Laboratory, New York, April 1994.

38. Burns JC and Chen TT. Pantropic retroviral vectors for gene transfer in fish and marine invertebrates. Presented at California Consortium for Marine Biotechnology Conference: Marine Biotechnology: Emerging economic opportunities in California. San Diego, CA, October 1994.

39. Matsubara T, Lozinski G, Yee J-K, Pott G, James AA, Burns JC. Novel pantropic retroviral vectors mediate gene transfer in mosquito cell lines. Presented at the American Society of Tropical Medicine and Hygiene, Cincinnati, Ohio, November 1994.

40. Shimizu C, Huber SA, Burns JC. Quantitative analysis of cytokine mRNA expression suggests predominance of Th2-like response in experimental enteroviral myocarditis. Presented at the American Heart Assoc. Meeting, Dallas, TX, November 1994. Circulation 90: Abs #1423, 1994.

41. Burns JC, Matsubara T, Higgs S, James AA. Foreign gene expression in mosquito cell lines mediated by pantropic retroviral vectors. Presented at the Keystone Meeting, Toward the Genetic Manipulation of Insects, Tamarron, CO, March 1995. J. Cellular Biochem. 21A:222, 1995.

42. Burns JC, Glode MP, Capparelli E, Brown JA, Newburger JW and the US/Canadian Multicenter Kawasaki Disease Study Group. Intravenous gamma globulin in the treatment of Kawasaki Syndrome: Are all brands equal? Presented at the Society for Pediatric Research, San Diego, CA, May 1995, and the 5th International Kawasaki Disease Symposium, Fukuoka, Japan, May 1995. Pediatr. Res. 37: Abs #1009, 1995.

43. Matsubara T, Beeman RW, Besansky NJ, Mukabayire O, Higgs S, James AA, Burns JC. Pantropic retroviral infection of mosquito cell lines. Presented at the Am. Soc. of Tropical Medicine and Hygiene Meeting, San Antonio, November, 1995.

44. Franco MD, Burns JC, Vogt RG. Development of a MoMLV retroviral system for in vivo expression analysis of OBP proteins in the moth Manduca sexta. Soc. for Neuroscience 21:133, 1995.

45. Burns JC, Shike H, Frencia A, Yardley K, James AA. Vectors for vectors: New approaches to disease control with pantropic retroviral vectors. Presented at the Annual Meeting, Mosquito and Vector Control Assoc. of California, Rohnhert Park, CA, January 1996.

Jane C. Burns, M.D.

30

46. Shen Z, Xiong B, Lemos FJA, Frencia A, Burns JC, Jacobs-Lorena M. Gut-specific gene expression in insects of medical importance. Presented at the Brazilian Society of Biochemistry and Molecular Biology, Caxambu, Brazil, May 1996.

47. Burns JC, Higgs S, Jacobs-Lorena M, Fang Q, Matsubara T, Frencia A, Davis B, Bennett M, Yardley K, James AA. Gene transfer in mosquitoes with pantropic retroviral vectors. Presented at the American Society for Tropical Medicine and Hygeine Meeting, Baltimore, MD, December 1996.

48. Jacobs-Lorena M, Unnasch TR, Toe L, Shike H, Fang Q, Burns JC. Gene transfer into the mosquito and black fly gut by pantropic retroviral vectors. Presented at the American Society for Tropical Medicine and Hygeine, Baltimore, MD, December 1996.

49. Burns JC, Fang Q, Shike H, Higgs S, Davis B, Jacobs-Lorena M. Gene transfer in mosquitoes with pantropic retroviral vectors. Presented at the Mosquito and Vector Control Association of California, Modesto, CA, January, 1997.

50. Dengler LD, Capperelli EV, Bastian J, Bradley DJ, Glode MP, Santa S, Newburger JW, Baker AL, Burns JC. Cerebrospinal fluid profile in patients with acute Kawasaki disease. Presented at the Western Society for Pediatric Research, Carmel, CA, February 1997. J. Invest. Med. 45:89A, 1997.

51. Ting E, Capparelli EV, Billman GF, Lavine J, Burns JC. Elevated γ-glutamyl transpeptisdase levels in serum of patients with acute Kawasaki disease. Presented at the Western Society for Pediatric Research, Carmel, CA, February 1997. J. Invest. Med. 45:85A, 1997.

52. Burns JC, Capparelli E, Brown JA, Newburger JW, Glode MP and the Multicenter Kawasaki Study Group. Intravenous gamma globulin treatment and retreatment in Kawasaki disease. Presented at the Infectious Diseases Society of America, San Francisco, CA, September 1997.

53. Xuchu Q, Alagon A, Shike H, Hirata K, Burns JC, Reed SL. Pantropic retroviral vectors mediate stable transfer and expression in Entamoeba histolytica. Presented at the Molecular Parasitology Meeting, Woods Hole, MA, September 1997.

54. Boulo V, Cadoret, JP, Cedeno, V, Miahle, E, Burns, JC. Transfer of heterologous DNA into oyster primary cell cultures by retroviral pseudotypes. Presented at the 2nd International Workshop on Trangenesis of Invertebrate Organisms. Asilomar, CA, May 1997.

55. Omachi T, Shike H, Higgs S, Burns JC. Gene transfer with retoviral vectors pseudotyped with Sindbis virus envelope glycoproteins. Presented at the Keystone Symposium, "Toward the genetic manipulation of insects", Taos, New Mexico, January 1998.

56. Burns JC. Pantropic retroviral vectors for gene transfer in insects. Presented at the Keystone Symposium, "Toward the genetic manipulation of insects", Taos, New Mexico, January 1998.

57. Bronstein DE, Zhang Q, Stroupe C, Burns JC, Shike H, Bastian JF, Newburger JW, Quasney MW. Polymorphisms within the locus for tumor necrosis factor in children with Kawasaki Disease. Presented at IDSA, Denver, CO, November 1998.

58. Que X, Alagon A, Hirata K, Shimizu C, Burns JC, Reed SL. Stable integration of foreign DNA into the genome of Entabmoeba histolytica by pantropic retroviral vectors.

Jane C. Burns, M.D.

31

Presented at American Society of Tropical Medicine and Hygiene, San Juan, Puerto Rico, October 1998.

59. Komoto N, Fayard C, Boulo V, Burns JC, Couble P. Infection of the silkworm with a pseudotyped retroviral vector. Presented at the Japanese Society of Sericultural Science, Ueda Nagano, Japan, April 3, 1999.

60. Carlberg J, Mitchel S, Schipper A, Burns JC. Gene transfer into bass with pantropic retroviral vectors. Presented a the World Aquaculture Society Meeting, Sydney, Australia, May 1999.

61. Dille A, Bronstein DE, Burns JC. Active vs. passive surveillance for Kawasaki disease in San Diego County, California. Proceedings of the Sixth International Kawasaki Disease Symposium, Waikoloa, Hawaii, Feb 11-14, 1999. Ped Res 47:550, 2000.

62. Bronstein DE, Burns JC, Dille AN, Shike H, Bastian JF, Newburger JW, Matsubara T, Zhang Q, Stroupe C, Quasney M. Tumor necrosis factor alpha and lymphotoxin alpha gene polymorphisms in children with Kawasaki disease. Proceedings of the Sixth International Kawasaki Disease Symposium, Waikoloa, Hawaii, Feb 11-14, 1999. Ped Res 47:551, 2000.

63. Burns JC, Capparelli EV, Newburger JW, Glode MP and the U.S./Canadian Kawasaki Syndrome Study Group. Intravenous gamma globulin treatment and retreatment. Proceedings of the Sixth International Kawasaki Disease Symposium, Waikoloa, Hawaii, Feb 11-14, 1999. Ped Res 47:553, 2000.

64. Eberhard BA, Sundel RP, Burns JC, Newburger JW, Baker A, Gellis SE. Psoriasis in Kawasaki Disease.Proceedings of the Sixth International Kawasaki Disease Symposium, Waikoloa, Hawaii, Feb 11-14, 1999. Ped Res 47:552, 2000.

65. Quasney MW, Zhang Q, Stroupe C, Bronstein DE, Shike H, Bastian JF, Newburger JW, Burns JC. Genetic polymorphisms in the regulatory region of the TNF-alpha gene in children with Kawasaki disease. Presented at the Pediatric Academic Societies' Annual Meetiing, San Francisco, CA, May 1-4, 1999. Ped Res 45:171A, 1999.

66. Burns JC, Shimizu C, Shike H. Pantropic retroviral vectors for gene transfer in invertebrates. Presented at the 3rd International Workshop on Transgenesis of Invertebrate Organisms, Kolymbari, Crete, August 1999.

67. Shike H, Shimizu C, Dhar AK, Klimpel KR, Burns JC. Pantropic retroviral vectors mediate foreign gene expression in shrimp (Penaeus stylirostris). Presented at the 3rd International Workshop on Transgenesis of Invertebrate Organisms, Kolymbari, Crete, August 1999.

68. Boulo V, Burns JC, Shike H, Shimizu C, Miahle E, Cadoret JP. Expression and integration of genetic sequences in primary cultured cells from the Pacific oyster, Crassostrea gigas. Presented at the 3rd International Workshop on Transgenesis of Invertebrate Organisms, Kolymbari, Crete, August 1999.

69. Boulo V, Cadoret JP, Shike H, Shimizu C, Burns JC. Infection by pantropic retroviral vectors of primary cultured cells from the oyster, Crassostrea gigas. Presented at the World Aquaculture Society Meeeting, Nice, France, May 2000.

70. Shimizu C, Shike H, Dhar AK, Klimpel KR, Burns JC. Pantropic retroviral vectors mediate foreign gene expression in shrimp (Penaeus stylirostris). Presented at the World

Jane C. Burns, M.D.

32

Aquaculture Society Meeeting, Nice, France, May 2000. 71. Burns JC, Shimizu C, Shike H. Pantropic retroviral vectors for gene transfer in

aquaculture species. Presented at the World Aquaculture Society Meeeting, Nice, France, May 2000.

72. Shike H, Shimizu C, Klimpel KR, Burns JC. Pantropic retroviral vectors mediate foreign gene expression in shrimp (Penaeus stylirostris). Presented at the Society for In Vitro Biology, San Diego, CA June 2000; In Vitro Cell. Develop. Biol. 36:37A, 2000.

73. Boulo V, Moore JD, Shimizu C, Friedmann CS, Burns JC. Infection of primary cultured cells from two oyster species by pantropic retroviral vectors. Presented at the Society for In Vitro Biology, San Diego, CA June 2000; In Vitro Cell. Develop. Biol. 36:37A, 2000.

74. Burns JC, Shimizu C, Boulo V, Shike H. Pantropic retroviral vectors for gene transfer into invertebrate cells. Presented at the Society for In Vitro Biology, San Diego, CA June 2000; In Vitro Cell. Develop. Biol. 36:12-A, 2000.

75. Burns JC, Bakalis S, Boulo V. Pantropic retroviral vectors for gene expression in fish cell lines: Toward a rational approach to genetic engineering of deisease resistance in fish.cells. Presented at the Society for In Vitro Biology, San Diego, CA June 2000; In Vitro Cell. Develop. Biol. 36:7A, 2000.

Discontinued tracking abstracts in 2000.

jane c. burns md - ucsd jacobs school of...

Documents